Scarica l'app Stockscreener
0.5906
3.10%
-0.0189
Dopo l'orario di chiusura:
.60
0.0094
+1.59%
Precedente Chiudi:
$0.6095
Aprire:
$0.6075
Volume 24 ore:
44,772
Relative Volume:
0.13
Capitalizzazione di mercato:
$5.23M
Reddito:
$11.42M
Utile/perdita netta:
$-2.89M
Rapporto P/E:
-1.5501
EPS:
-0.381
Flusso di cassa netto:
$-1.38M
1 W Prestazione:
-2.54%
1M Prestazione:
-0.08%
6M Prestazione:
-75.08%
1 anno Prestazione:
-77.37%
Intervallo 1D:
$0.5903
$0.6075
Intervallo di 1 settimana:
$0.58
$0.64
Portata 52W:
$0.56
$2.968
Nexgel Inc Stock (NXGL) Company Profile
Nome
Nexgel Inc
Settore
Industria
Telefono
215 702-8550
Indirizzo
2150 CABOT BLVD WEST,, LANGHORNE
Compare NXGL vs ISRG, BDX, MDLN, ALC, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NXGL
Nexgel Inc
|
0.5906 | 5.39M | 11.42M | -2.89M | -1.38M | -0.381 |
ISRG
Intuitive Surgical Inc
|
451.38 | 160.21B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
144.17 | 41.62B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
45.32 | 37.37B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
74.45 | 35.82B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
207.88 | 30.38B | 5.40B | 1.49B | 1.78B | 10.12 |
Nexgel Inc Borsa (NXGL) Ultime notizie
NEXGEL Appoints Ian Blackman CFO Amid Celularity Deal - MyChesCo
NexGel Inc Warrant (NXGLW) - Minichart
NexGel Appoints Ian Blackman as New Chief Financial Officer - The Globe and Mail
NexGel, Inc. 2025 SEC Filing – Executive Compensation, Corporate Governance, Ownership & Audit Disclosure - Minichart
Board pay, ownership and new CFO terms at NexGel (NASDAQ: NXGL) - Stock Titan
NEXGEL (NASDAQ: NXGL) hires new CFO to support Celularity deal - Stock Titan
Maxim Group Maintains NexGel(NXGL.US) With Buy Rating, Maintains Target Price $2 - Moomoo
NEXGEL Closes Celularity Asset Deal, Launches BioNX Surgical - MyChesCo
Asymmetry Point LP (NXGL) files Schedule 13G/A showing 8.8% ownership - Stock Titan
NEXGEL expects pro forma annual revenue of roughly $35M following Celularity wound segment acquisition - MSN
Langhorne’s Nexgel Transforms Near Disaster into ‘Three-Team Trade’ Acquisition - BUCKSCO.Today
NEXGEL Appoints Ian Blackman as Chief Financial Officer - Investing News Network
Nexgel, Inc. Appoints Ian Blackman as Chief Financial Officer - marketscreener.com
Inside the deal: After investor bails, Nexgel scrambles to save acquisition that will triple revenue - The Business Journals
NexGel receives Nasdaq notice for minimum bid price deficiency By Investing.com - Investing.com India
NEXGEL, INC. Receives Nasdaq Delisting Notice for Failure to Meet Minimum Bid Price Requirement - Minichart
NexGel receives Nasdaq notice for minimum bid price deficiency - Investing.com
NexGel Receives Nasdaq Deficiency Notice Over Bid Price - TipRanks
NexGel Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
NexGel (NASDAQ: NXGL) warned by Nasdaq over sub-$1 share price and delisting risk - Stock Titan
NXGL (NexGel Inc) shares fall over 15 percent after Q4 2025 EPS loss lands far below analyst consensus estimates.Fast Rising Picks - Xã Thanh Hà
NexGel Bets Big With Transformational Acquisition And Financing - The Globe and Mail
NEXGEL Reschedules Shareholder Call, Revises Celularity Financing - MyChesCo
NEXGEL closes Celularity biomaterials deal, raises $5.5 million By Investing.com - Investing.com India
Celularity Announces Closing of Transaction with NexGel - Investing News Network
NXGL: Acquisition triples revenue and accelerates profitability, transforming the business platform - TradingView
Nexgel Inc co and Celularity enter amendment no. 1 to license agreement on April 17, 2026 - marketscreener.com
Nexgel IncCo to Pay Celularity $13.3 Mln I - Moomoo
NEXGEL Secures Strategic Financing and Regenerative Portfolio License - TipRanks
NexGel Closes Celularity Biomaterials License Terms and Secures $6.9M Convertible Note Financing - TradingView
NEXGEL (NASDAQ: NXGL) triples revenue outlook with Celularity deal, $6.9M notes - Stock Titan
Celularity Inc. announced that it has received $13.3 million in funding from NEXGEL, Inc. - marketscreener.com
NexGel closes acquisition of products from Celularity - TipRanks
Celularity Closes $13.3 Million Asset Sale to NexGel, Strengthening Focus on Longevity Therapeutics and Balance Sheet 1 - Minichart
NEXGEL New Strategic Partner, Sequence LifeScience, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease Segment - Investing News Network
Nexgel new strategic partner, Sequence LifeScience, leads financing with $5.5 million to complete acquisition of Celularity degenerative disease segment - marketscreener.com
Celularity Closes NexGel Asset Sale, Refocuses on Cell Therapy - TipRanks
NEXGEL closes Celularity biomaterials deal, raises $5.5 million - Investing.com
Biomaterials company Nexgel announces a key partnership with new strategic partner Sequence Lifescience™ - Bitget
NEXGEL New Strategic Partner, Sequence LifeScience™, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease Segment - The Manila Times
Celularity (NASDAQ: CELU) closes NexGel asset sale as Helena note default looms - Stock Titan
Celularity Closes Transaction with NexGel to Monetize Biomaterials - Intellectia AI
Celularity sells biomaterials assets, cuts nearly $13M of debt - Stock Titan
NexGel Inc stock (US65340W1027): Is its hydrogel tech edge strong enough for medtech growth? - AD HOC NEWS
NEXGEL, Inc. completed the acquisition of Portfolio of Commercial-stage Regenerative Biomaterial Products of Celularity Inc. for 15.8 million. - marketscreener.com
NEXGEL reschedules shareholder call, revises financing plan - MSN
NexGel Inc stock (US65340W1027): Why its hydrogel tech edge matter more now for specialized medical - AD HOC NEWS
NEXGEL (NXGL) price target decreased by 66.67% to 2.04 - MSN
NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET - The Manila Times
NEXGEL signs agreement to acquire regenerative biomaterial portfolio - MSN
Nexgel Inc Azioni (NXGL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.78%
0.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):